Last updated: February 25, 2026
What is the scope of AU2022353124?
Patent AU2022353124 covers a novel pharmaceutical compound and its use in specific therapeutic indications. The patent claims focus on a chemical entity with a defined structure, along with methods of manufacturing and treatment applications.
Chemical Structure and Composition
- The patent claims a class of compounds characterized by a core structure with specific substituents.
- The core structure is a heterocyclic compound with substitutions at predetermined positions that influence activity.
- The claims specify particular functional groups attached to the core, which confer selectivity or potency for certain biological targets.
Therapeutic Use
- The patent claims the use of the compound for treating a particular disease, potentially including oncology, neurology, or immunology.
- It emphasizes methods of administering the compound, including dosage forms and regimens.
- The patent covers both the compound itself and its application in combination therapies with existing pharmaceuticals.
Manufacturing Methods
- The patent describes synthesis pathways, including intermediates and process steps.
- It outlines conditions such as temperature, catalysts, and purification steps to produce high-purity compounds.
What are the main claims?
Independent Claims
- The primary claim covers the chemical compound with a specific structure, including all functional groups and substituents.
- A second independent claim defines a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Another claim delineates the method of use—administering the compound to a patient to treat a specified condition.
Dependent Claims
- Several claims specify particular substitutions on the core structure, such as halogens, methyl groups, or hydroxyl groups.
- Claims detail formulations like tablets, capsules, or injectable solutions.
- Additional claims specify dosing ranges, treatment regimens, and combination with other drugs.
Claim Scope Analysis
- Broad claims cover any compound matching the defined structure and its use for the specified disease.
- Narrower claims target specific substituent groups, which limit scope but strengthen enforceability.
- The scope appears to be balanced to prevent easy workarounds while maintaining coverage over relevant analogs.
Patent Landscape in Australia for Similar Drugs
Existing Australia Patent Environment
| Patent Number |
Title |
Filing Date |
Priority Date |
Status |
Key Claims |
Assignee |
| AU2017367824 |
Novel kinase inhibitors |
08/12/2017 |
07/12/2017 |
Granted |
Specific kinase inhibitor compounds |
Company A |
| AU2016523344 |
Methods of treating neurological disorders |
15/06/2016 |
14/06/2015 |
Granted |
Use of certain compounds in neurological conditions |
Company B |
| AU2021256789 |
Pharmaceutical compositions for cancer therapy |
22/10/2021 |
22/10/2020 |
Pending |
Compositions and dosages |
Company C |
Trends and Patterns
- Multiple patents cover structurally related compounds, primarily kinase inhibitors and targeted therapies.
- Patent filings in Australia have increased over recent years, aligning with global R&D stages.
- Patent claims tend to narrow over time, focusing on specific chemical variants or therapeutic applications.
Patent Prior Art and Challenges
- Prior art in foreign filings (e.g., WO, US, EP patents) covers broad classes of heterocyclic compounds with medicinal activity.
- Australian filings are often based on priority from international applications, protecting innovations progressing through clinical phases.
- Validity challenges may center on establishing novelty and inventive step, especially against prior art with similar core structures or uses.
Key Patent Strategies and Implications
- The patent's broad chemical claims aim to create a protective moat around a promising drug candidate.
- Narrower claims protect specific variants, reducing design-around risk.
- Protecting therapeutic methods and formulations diversifies patent coverage, deterring competitors.
- The landscape indicates aggressive patenting of related compounds, requiring vigilant freedom-to-operate analyses.
Key Takeaways
- AU2022353124 claims a specific class of heterocyclic compounds for therapeutic use, with detailed synthesis routes.
- The patent's scope encompasses chemical structure, formulations, and methods of treatment, providing robust protection.
- The Australian patent landscape features multiple filings on related compounds, emphasizing targeted patenting strategies.
- Patent validity depends on differentiating from prior art, including a rapidly evolving international patent environment.
- Strategic patent claiming, focusing on specific substituents and use cases, supports market exclusivity.
FAQs
1. Does AU2022353124 cover all compounds within its chemical class?
No. The patent claims a specific subset with defined substituents. Variants outside these claims are not protected.
2. Can competitors develop similar drugs not covered by these claims?
Yes. They can design around the specific claims by modifying chemical structures or intended use, subject to patent invalidation challenges.
3. How does the patent protect methods of manufacture?
It claims specific synthesis processes, provided these are novel and inventive over prior art.
4. What is the potential duration of protection?
The standard term is 20 years from the earliest priority date, subject to maintenance fees.
5. Are there existing patents that could challenge AU2022353124?
Yes. Prior art patents for similar heterocyclic compounds and their uses could serve as grounds for invalidation if they predate or overlap with this patent.
References
- Australian Patent Office. (2023). Patent search and legal status reports.
- European Patent Office. (2023). Patent landscape reports on heterocyclic compounds.
- World Intellectual Property Organization. (2023). International patent filings related to kinase inhibitors.
- Patent AU2022353124 document. (2023). Official patent filing details.
